Neurogen , Webcast of Insomnia Focus

Sept. 18, 2007--Neurogen Corporation (Nasdaq: NRGN), a drug discovery and development company, announced the webcast of its Insomnia Focus Investor meeting on September 25, 2007, from 11:45 a.m. to 2:00 p.m. ET.

Neurogen and guest speakers will take an in-depth look at insomnia therapeutics on the market and in development, and the role of NRGN's adipiplon (formerly NG2-73) in this changing marketplace. Guest speakers are... Neurogen's Press Release -